A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 428,759 shares of LLY stock, worth $324 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
428,759
Previous 441,882 2.97%
Holding current value
$324 Million
Previous $400 Million 5.05%
% of portfolio
1.18%
Previous 1.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $10.1 Million - $12.6 Million
-13,123 Reduced 2.97%
428,759 $380 Million
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $4.42 Million - $5.55 Million
-6,102 Reduced 1.36%
441,882 $400 Million
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $1.97 Million - $2.63 Million
-3,322 Reduced 0.74%
447,984 $349 Million
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $1.57 Million - $1.85 Million
-2,994 Reduced 0.66%
451,306 $263 Million
Q3 2023

Oct 23, 2023

SELL
$434.7 - $599.3 $2.17 Million - $2.99 Million
-4,983 Reduced 1.08%
454,300 $244 Million
Q2 2023

Jul 25, 2023

SELL
$350.74 - $468.98 $1.63 Million - $2.18 Million
-4,646 Reduced 1.0%
459,283 $215 Million
Q1 2023

May 17, 2023

BUY
$310.63 - $364.82 $140 Million - $164 Million
449,826 Added 3189.58%
463,929 $159 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $138 Million - $162 Million
-445,297 Reduced 96.93%
14,103 $4.84 Billion
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $8.92 Million - $10.4 Million
-27,731 Reduced 5.69%
459,400 $168 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $1.58 Million - $1.8 Million
5,341 Added 1.11%
487,131 $158 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $416,980 - $489,595
-1,496 Reduced 0.31%
481,790 $156 Million
Q1 2022

Apr 27, 2022

BUY
$234.69 - $291.66 $291,250 - $361,950
1,241 Added 0.26%
483,286 $138 Million
Q4 2021

Jan 31, 2022

SELL
$224.85 - $279.04 $10.8 Million - $13.4 Million
-48,137 Reduced 9.08%
482,045 $133 Million
Q3 2021

Oct 20, 2021

SELL
$221.6 - $272.71 $4.53 Million - $5.58 Million
-20,461 Reduced 3.72%
530,182 $122 Million
Q2 2021

Jul 20, 2021

SELL
$180.55 - $233.54 $4.49 Million - $5.8 Million
-24,855 Reduced 4.32%
550,643 $126 Million
Q1 2021

Apr 22, 2021

SELL
$164.32 - $212.72 $6.18 Million - $8 Million
-37,623 Reduced 6.14%
575,498 $108 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $2.25 Million - $2.98 Million
-17,247 Reduced 2.74%
613,121 $104 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $13.1 Million - $15.1 Million
-89,265 Reduced 12.4%
630,368 $93.3 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $5.52 Million - $6.64 Million
-40,433 Reduced 5.32%
719,633 $118 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $1.44 Million - $1.78 Million
12,109 Added 1.62%
760,066 $105 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $492,259 - $609,707
-4,604 Reduced 0.61%
747,957 $98.3 Million
Q3 2019

Nov 20, 2019

BUY
$106.79 - $116.16 $2.73 Million - $2.97 Million
25,529 Added 3.51%
752,561 $84.2 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $93,285 - $108,887
842 Added 0.12%
727,032 $80.5 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $6.19 Million - $7.29 Million
-55,604 Reduced 7.11%
726,190 $85.2 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $915,823 - $1.03 Million
-8,648 Reduced 1.09%
781,794 $90.5 Million
Q3 2018

Oct 23, 2018

SELL
$85.86 - $107.31 $1.62 Million - $2.02 Million
-18,839 Reduced 2.33%
790,442 $84.8 Million
Q2 2018

Aug 02, 2018

SELL
$75.7 - $86.88 $863,812 - $991,387
-11,411 Reduced 1.39%
809,281 $69.1 Million
Q1 2018

Apr 10, 2018

SELL
$74.21 - $87.6 $1.91 Million - $2.25 Million
-25,704 Reduced 3.04%
820,692 $63.5 Million
Q4 2017

Jan 22, 2018

SELL
$81.94 - $87.89 $457,962 - $491,217
-5,589 Reduced 0.66%
846,396 $71.5 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $65.7 Million - $72.9 Million
851,985
851,985 $72.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.